SCHEMBL5503055

SCHEMBL5503055

O=C(CN1CCC(CN2CCCC2)C1)Nc1cccc(Nc2ncc(-c3ccsc3)cn2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.45
ALDH1A1 P00352 2/20 0.41
JAK3 P52333 1/20 0.41
CTSL P07711 1/20 0.40
CTSC P53634 1/20 0.40
DRD4 P21917 3/20 0.40
DRD2 P14416 1/20 0.40
LMNA P02545 3/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
MAPK1 P28482 1/20 0.39
RAB9A P51151 1/20 0.39
MAP4K4 O95819 1/20 0.38
EGFR P00533 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5503212 0.90 POLB (0.57) POLBALDH1A1JAK3CTSLCTSC
SCHEMBL5530225 0.86 PARP1 (0.49) POLBALDH1A1JAK3CTSLCTSC
SCHEMBL5521372 0.85 POLB (0.43) POLBALDH1A1JAK3CTSLCTSC
SCHEMBL5501739 0.82 ALDH1A1 (0.53) POLBALDH1A1JAK3LMNASMN1; SMN2
SCHEMBL5499974 0.80 KDM4E (0.49) POLBALDH1A1LMNAMAPTTHRB
SCHEMBL14342345 0.80 MAPT (0.48) ALDH1A1CTSLCTSCMAPTSMN1; SMN2
SCHEMBL5499872 0.78 THRB (0.50) POLBLMNAMAPTTHRBGAA
SCHEMBL5496779 0.78 KDM4E (0.51) ALDH1A1THRBKDM4E
SCHEMBL5534432 0.77 CTSC (0.52) POLBALDH1A1JAK3CTSLCTSC
SCHEMBL5500635 0.77 HRH3 (0.43) ALDH1A1CTSCLMNATHRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US claimed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP claimed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO claimed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 US disclosed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 EP disclosed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293484-A1 Thiophene Heteroaryl Amines TTK, CHEK2, ABL1 POLB 2355/4885ALDH1A1 3195/4885JAK3 318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.